CFO Chester Zygmont III Sells Shares for Tax Withholding on Vesting RSUs

Chester S. Zygmont III, Chief Financial Officer of Revelation Biosciences, Inc. (REVB), filed a Form 4 reporting the sale of 13,285 shares of common stock at a weighted average price of $1.10 per share on April 30, 2026. The transaction was mandatory and executed to satisfy tax withholding obligations arising from the vesting of restricted stock awards. The shares were sold in multiple transactions at prices ranging from $1.09 to $1.13. Following this sale, Zygmont's direct holdings decreased to 92,063 shares. The filing also discloses indirect holdings through The Zygmont Family Trust (2 shares) and Czeslaw Capital Fund, LLC, where Zygmont serves as sole manager. The transaction was reported as required for executive officers under Section 16 of the Securities Exchange Act.